SCHEMBL28527735

SCHEMBL28527735

NC(=O)OC1CCC(Nc2ccccc2[N+](=O)[O-])CC1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HCAR3 P49019 3/20 0.50
▸ MAPK1 P28482 3/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ PDE5A O76074 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ MAPT P10636 5/20 0.43
▸ GLA P06280 1/20 0.43
▸ DCTPP1 Q9H773 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL718625 0.83 MAPK1 (0.65) HCAR3MAPK1SMN1; SMN2ALDH1A1GAA
SCHEMBL30536224 0.81 MAPK1 (0.54) HCAR3MAPK1SMN1; SMN2ALDH1A1GAA
SCHEMBL16445204 0.80 HCAR3 (0.52) HCAR3MAPK1SMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL16445205 0.80 HCAR3 (0.52) HCAR3MAPK1SMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL28535213 0.80 KDM4E (0.55) MAPK1ALDH1A1GAAMAPT
SCHEMBL8724028 0.79 MAPK1 (0.61) HCAR3MAPK1SMN1; SMN2ALDH1A1GAA
SCHEMBL29065575 0.79 MAPK1 (0.58) HCAR3MAPK1SMN1; SMN2ALDH1A1GAA
SCHEMBL22725450 0.79 MAPK1 (0.58) HCAR3MAPK1SMN1; SMN2ALDH1A1GAA
SCHEMBL22725465 0.79 MAPK1 (0.58) HCAR3MAPK1SMN1; SMN2ALDH1A1GAA
SCHEMBL4129011 0.79 HCAR3 (0.58) HCAR3MAPK1SMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111848598-A Heterocyclic ring-containing compound, application thereof and composition containing heterocyclic ring-containing compound 健艾仕生物医药有限公司 2020-10-30 — — CN disclosed
Send feedback